Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) Short Interest Up 284.8% in May

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) was the recipient of a large growth in short interest during the month of May. As of May 15th, there was short interest totaling 79,267 shares, a growth of 284.8% from the April 30th total of 20,598 shares. Based on an average daily volume of 61,665 shares, the short-interest ratio is presently 1.3 days. Approximately 0.0% of the shares of the stock are sold short.

Otsuka Price Performance

OTSKY stock traded up $1.38 on Friday, reaching $36.51. The company had a trading volume of 44,009 shares, compared to its average volume of 34,101. Otsuka has a 1 year low of $21.68 and a 1 year high of $37.52. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.67 and a current ratio of 2.17. The company’s fifty day moving average is $34.91 and its 200 day moving average is $31.82. The company has a market cap of $39.22 billion and a P/E ratio of 15.41.

Otsuka (OTCMKTS:OTSKY) last issued its quarterly earnings results on Tuesday, April 28th. The company reported $0.59 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.16. The company had revenue of $3.96 billion during the quarter, compared to the consensus estimate of $3.78 billion. Otsuka had a return on equity of 12.33% and a net margin of 15.01%.Otsuka has set its FY 2026 guidance at 1.610-1.610 EPS. On average, research analysts forecast that Otsuka will post 1.99 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms recently issued reports on OTSKY. Zacks Research raised Otsuka from a “strong sell” rating to a “hold” rating in a research note on Tuesday, March 31st. The Goldman Sachs Group lowered Otsuka from a “strong-buy” rating to a “strong sell” rating in a research note on Friday, February 27th. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold”.

About Otsuka

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.